“According to Roots Analysis, the Next Generation Sequencing Market is estimated to be worth $3.6 billion. The market is forecasted to grow at a compound annual growth rate (CAGR) of 18% in the forecast period.
The report encompasses the global industry’s size, current trends, regional market share, demand, recent advancements, and potential business prospects. The report’s title is “Next Generation Sequencing Market Size, Share, Analysis 2035.’’
Next Generation Sequencing Market Segmentation:
The market report titled "Next Generation Sequencing Market, 2020-2030: Service Providers (Whole Genome, Whole Exome, and Targeted Sequencing) and Technology Platforms" presents a comprehensive analysis of the present market scenario, including market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future prospects in the NGS market.
Regional Analysis of the Next Generation Sequencing Market
In terms of geographical segmentation, the Next Generation Sequencing Market is divided into North America, Europe, Asia-Pacific, and Rest of the World. The report features an extensive study of the current market landscape, market size and future opportunities for the Next Generation Sequencing Market companies either developing the drugs or providing the necessary Next Generation Sequencing Market, during the forecast period.
The following are the major objectives of the study:
- To delineate, depict, and predict the Next Generation Sequencing Market’s attributes based on Key Application Areas, End Users, Type of Technology, Type of Services and Key Geographical Regions.
- To furnish comprehensive information regarding the key factors influencing Industry growth, encompassing drivers, limitations, opportunities, and challenges.
- To conduct a strategic examination of micro-industries, focusing on their individual growth patterns, prospects, and contributions to the broader industry.
- To scrutinize Industry opportunities for key stakeholders and provide an in-depth analysis of the competitive landscape among major industry leaders.
- To project the dimensions of Industry segments across major regions: North America, Europe, Asia-Pacific, and Rest of the World.
- To outline the profiles of key players in the industry and thoroughly assess their market shares and core competencies.
The key companies in the Next Generation Sequencing Market are.
Admera Health, Applied Biological Materials, BGI Genomics, CD Genomics, DNA Link, Eurofins Genomics (Eurofins Scientific), Fulgent Genetics, Gene by Gene, GENEWIZ, MedGenome, Novogene, Omega Biosciences, Psomagen, Veritas Genetics and Xcerlis Labs.
Major Points in TOC:
- Preface
- Research Methodology
- Introduction
- Genome Sequencing Service Providers: Market Landscape
- Genome Sequencing Service Providers
- Patent Analysis
- Market Forecast
- Future Opportunities
TOC Continued…………….
Frequently Asked Questions
- What is the size of the next generation sequencing market?
- Which companies are at the forefront of the next generation sequencing market?
- How many clinical trials have been registered by companies involved in the next generation sequencing market to evaluate various therapeutics using gene sequencing data?
- How many patents associated with next generation sequencing have been filed or granted in recent years?
- What does next generation sequencing entail?
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html
Browse More Related Reports
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415